Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series

Since the COVID-19 pandemic, CoronaVac, an inactivated SARS-CoV-2 vaccine, has been widely deployed in several countries for emergency use. However, the immunogenicity of the inactivated vaccine was relatively lower when compared to other vaccine types and was even more attenuated in autoimmune pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Assawasaksakul, Theerada, Sathitratanacheewin, Seelwan, Vichaiwattana, Preeyaporn, Wanlapakorn, Nasamon, Poovorawan, Yong, Kittanamongkolchai, Wonngarm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646968/
https://www.ncbi.nlm.nih.gov/pubmed/34862313
http://dx.doi.org/10.1136/rmdopen-2021-002019

Ejemplares similares

Ejemplares similares